TY  - JOUR 
T1  - Drug development for sickle cell disease: repeated setbacks, yet there remains an optimistic outlook for future breakthroughs
JO  - Hematology, Transfusion and Cell Therapy
A1  - Cançado, Rodolfo
A1  - Costa, Fernando Ferreira
SN  - 2531-1379
UL  - 10.1016/j.htct.2025.106251
VL  - 48 
Y1  - 2026
PB  - Brasil 
ER  -